Company profile

Timothy C. Crew
Incorporated in
Fiscal year end
IRS number

LCI stock data



7 May 20
4 Jul 20
30 Jun 21


Company financial data Financial data

Quarter (USD) Mar 20 Dec 19 Sep 19 Jun 19
Revenue 144.37M 136.11M 127.34M 133.84M
Net income -16.59M 5.08M -12.16M -7.59M
Diluted EPS -0.43 0.13 -0.32 -0.2
Net profit margin -11.49% 3.74% -9.55% -5.67%
Operating income -2.09M 16.78M 9.4M 9.4M
Net change in cash -17.72M 18.17M -39.24M -64.96M
Cash on hand 101.46M 119.18M 101.01M 140.25M
Cost of revenue
Annual (USD) Jun 19 Jun 18 Jun 17 Jun 16
Revenue 655.41M 684.56M 633.34M 542.49M
Net income -272.11M 28.69M -547K 44.86M
Diluted EPS -7.2 0.75 -0.02 1.2
Net profit margin -41.52% 4.19% -0.09% 8.27%
Operating income -262.32M 129.7M 86.45M 130.76M
Net change in cash 41.66M -19.15M -107.03M 24.43M
Cash on hand 140.25M 98.59M 117.74M 224.77M
Cost of revenue

Financial data from Lannett earnings reports

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
1 Jul 20 Landis G. Michael Common Stock Payment of exercise Dispose F No 7.07 392 2.77K 37,294
19 May 20 Drabik David A Common Stock Sell Dispose S No 7.37 37,220 274.31K 45,972
19 May 20 Taveira Paul Common Stock Sell Dispose S No 7.22 30,000 216.6K 51,415
12 May 20 Crew Timothy C Common stock Buy Aquire P Yes 7.57 3,000 22.71K 190,738
7 May 20 Cavanaugh Maureen Common Stock Payment of exercise Dispose F No 7.58 2,384 18.07K 61,589
31 Mar 20 Crew Timothy C Common stock Other Aquire J No 5.91 1,171 6.92K 187,738
90.8% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 149 170 -12.4%
Opened positions 14 39 -64.1%
Closed positions 35 37 -5.4%
Increased positions 53 50 +6.0%
Reduced positions 47 49 -4.1%
13F shares
Current Prev Q Change
Total value 1.48B 1.85B -20.0%
Total shares 36.64M 39.84M -8.0%
Total puts 831.5K 1.28M -35.1%
Total calls 376.4K 866.1K -56.5%
Total put/call ratio 2.2 1.5 +49.3%
Largest owners
Shares Value Change
Telemus Capital 7.69M $58.84M +0.2%
BLK BlackRock 5.16M $35.89M -1.2%
JPM JPMorgan Chase & Co. 3M $20.85M +9.6%
D. E. Shaw & Co. 2.66M $18.48M -22.1%
Vanguard 2.19M $15.26M -7.0%
LSV Asset Management 2.12M $14.71M +1.7%
STT State Street 1.31M $9.1M +1.0%
Renaissance Technologies 1.09M $7.55M -15.9%
Dimensional Fund Advisors 802.26K $5.58M +1.6%
IVZ Invesco 691.61K $4.81M +6.2%
Largest transactions
Shares Bought/sold Change
D. E. Shaw & Co. 2.66M -752.87K -22.1%
Public Sector Pension Investment Board 75K -594.32K -88.8%
Arrowstreet Capital, Limited Partnership 262.07K -439.91K -62.7%
PRU Prudential Financial 239.06K -344.47K -59.0%
JPM JPMorgan Chase & Co. 3M +263.43K +9.6%
Renaissance Technologies 1.09M -206.1K -15.9%
Vanguard 2.19M -165.98K -7.0%
Canada Pension Plan Investment Board 166.48K -160.29K -49.1%
Oxford Asset Management 0 -127.23K EXIT

Financial report summary

Impax LaboratoriesMylan
Content analysis ?
H.S. sophomore Avg
New words: absenteeism, adhere, Aid, alternative, Amantadine, argue, attendance, attention, carefully, carryback, CDC, Chancery, check, China, cleaning, combat, combating, confidence, criteria, cybersecurity, deductibility, deemed, deferral, detrimental, discouraging, disease, distancing, divert, duration, emerged, enclosing, encountered, enhanced, epidemic, essential, evolving, experienced, experiencing, floor, fogging, foregoing, formal, HCL, HCTZ, healthcare, HIV, hold, home, hygiene, inability, incident, instability, instance, intact, interruption, job, joinder, jointly, LIBOR, lifted, lockdown, London, magnitude, Memorandum, monitor, network, Organization, outbreak, outlook, Oxycodone, pandemic, physician, Pilocarpine, political, powered, precautionary, prospect, public, quarantine, rapidly, refile, relief, reluctant, remote, remotely, respirator, retirement, rubber, sanitizing, screening, show, shut, situation, social, sort, speed, spread, strain, suspended, temporarily, thermal, travel, Triamterence, undergo, Understanding, underway, unknown, vendor, voluntary, weekly, widespread, worldwide, Wuhan
Removed: AB, automatically, bioequivalence, BX, CII, Concerta, equivalence, ER, fulfillment, informed, insufficient, licensing, meantime, mg, nonrenewal, perpetual, rating, recommend, recommended, regain, remained, substitutable, teleconference, therapeutically